Literature DB >> 31356805

Roseburia Species: Prime Candidates for Microbial Therapeutics in Inflammatory Bowel Disease.

Richard Kellermayer1.   

Abstract

Mesh：

Year:  2019        PMID： 31356805     DOI： 10.1053/j.gastro.2019.05.073

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

Review 1.  Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species.

Authors:  Kai Nie; Kejia Ma; Weiwei Luo; Zhaohua Shen; Zhenyu Yang; Mengwei Xiao; Ting Tong; Yuanyuan Yang; Xiaoyan Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-22       Impact factor: 5.293

2.  Altered microbial biogeography in an innate model of colitis.

Authors:  Antonia Boger-May; Theodore Reed; Diana LaTorre; Katelyn Ruley-Haase; Hunter Hoffman; Lauren English; Connor Roncagli; Anne-Marie Overstreet; David Boone
Journal:  Gut Microbes       Date:  2022 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.